IMDX

$2.88+5.11%visit website

Insight Molecular Diagnostics Inc.

Market Cap

$94M

Live price × SEC shares (Aug 3, 2026)

Sector

Health Care

Industry

Biotechnology

Beta (raw)

1.89

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

56.4

TTM to Jun 2026 · revenue

P/B

N/M

TTM to Jun 2026 · negative equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Revenue	260	1,139	32	239	1,670
Cost of revenue	121	643	17	82	863
Gross profit	139	496	15	157	807
Research & development	3,878	5,829	4,953	4,486	19,146
Total operating expenses	11,187	23,931	4,428	11,559	51,105
Operating income	(11,048)	(23,435)	(4,413)	(11,402)	(50,298)
Income tax	0.00	0.00	0.00	0.00	0.00
Net income	(10,854)	(22,955)	(4,290)	(11,260)	(49,359)
EPS (basic) ($)	(0.34)		(0.12)	(0.31)	—
EPS (diluted) ($)	(0.34)		(0.12)	(0.31)	—
Weighted avg. shares (basic)	32,033		34,519	36,750
Weighted avg. shares (diluted)	32,033		34,519	36,750

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 10, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 42 more quarters, back to Mar 2015, with Tormere Pro.

Signals

purchases / sales, 90d

Short Volume

34%

W/W +2.5pp

Market & Alt Data

News

Factor Profile

Pro

Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-04-27	2026-04-27	BROADWOOD PARTNERS, L.P.	10% Owner	Purchase	250.9K	$3.64	$913K	12.68M	View
2026-04-24	2026-04-27	BROADWOOD PARTNERS, L.P.	10% Owner	Purchase	38.9K	$3.53	$137K	12.43M	View
2026-04-23	2026-04-27	BROADWOOD PARTNERS, L.P.	10% Owner	Purchase	280.4K	$3.50	$982K	12.40M	View
2026-04-20	2026-04-20	BROADWOOD PARTNERS, L.P.	10% Owner	Purchase	40.7K	$3.88	$158K	12.11M	View
2026-04-17	2026-04-20	BROADWOOD PARTNERS, L.P.	10% Owner	Purchase	40.1K	$3.57	$143K	12.07M	View

1–5 of 7

1 / 2

Recent News

iMDx Welcomes New Diagnostics Sales Leader to Prepare for Planned GraftAssureDx Launch

Yahoo · 2026-10-14

Mayo Clinic and Cleveland Clinic are among centers involved in a kidney test's FDA submission

Stock Titan · 2026-10-14

iMDx to Participate in Virtual U.S. Bancorp I BTIG Kidney Health Forum with KOL Discussion and Investor Meetings

Yahoo · 2026-10-12

iMDx to Participate in Lake Street 10th Annual Best Ideas Growth “BIG10” Conference

Yahoo Finance · 2026-09-02

Here's Why We're A Bit Worried About Insight Molecular Diagnostics' (NASDAQ:IMDX) Cash Burn Situation

Simply Wall St · 2026-09-02

Insight Molecular Diagnostics (IMDX) Q2 2026 Earnings Call Transcript

Yahoo Finance · 2026-08-17

Oncocyte Eyes Faster, Less Invasive Heart Transplant Rejection Testing

Yahoo Finance · 2026-08-17

$IMDX stock is down 13% today. Here's what we see in our data.

Quiver Quantitative · 2026-08-13

Insight Molecular Diagnostics to Host Virtual KOL Event on August 17, 2026: Moving Toward In-House Heart Transplanted Organ Rejection Testing

Yahoo Finance · 2026-08-11

IMDX Forecast — Price Target — Prediction for 2027

TradingView · 2026-06-26

Breakthrough Science Meets Market Skepticism: Insight Molecular Diagnostics Inc. (IMDX)’s Defining Moment

Yahoo Finance · 2026-06-19

IMDX GraftAssure Assay Sets New Standard in Screening Kidney Transplant Patients Per American Journal of Transplantation

Yahoo Finance · 2026-06-11

Insight Molecular Diagnostics Inc. 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:IMDX) 2026-05-17

Seeking Alpha · 2026-05-17

symbol__ Stock Quote Price and Forecast

CNN · 2025-06-20

Informational purposes only, not investment advice.

Date	Insider	Type	Shares	Value
2026-04-27	BROADWOOD PARTNERS, L.P.	P	250,923	$913,133.89
2026-04-27	BROADWOOD PARTNERS, L.P.	P	0	$0
2026-04-24	BROADWOOD PARTNERS, L.P.	P	38,880	$137,083.1
2026-04-24	BROADWOOD PARTNERS, L.P.	P	0	$0
2026-04-23	BROADWOOD PARTNERS, L.P.	P	0	$0

IMDX

Financial Statements

Signals

Factor Profile

Recent News

Insight Molecular Diagnostics Inc. (IMDX)

Reporting Insiders

Factor Profile